Warning: The NCBI web site requires JavaScript to function. more...
Elucidation of the potential roles of matrix metalloproteinases in skeletal biology.
Krane SM.
Arthritis Res Ther. 2003;5(1):2-4. Epub 2002 Oct 8.
Related citations
Matrix metalloproteinases: role in arthritis.
Burrage PS, Mix KS, Brinckerhoff CE.
Front Biosci. 2006 Jan 1;11:529-43. Review.
Matrix metalloproteinases and bone.
Krane SM, Inada M.
Bone. 2008 Jul;43(1):7-18. Epub 2008 Apr 4. Review.
Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritis.
Mix KS, Sporn MB, Brinckerhoff CE, Eyre D, Schurman DJ.
Clin Orthop Relat Res. 2004 Oct;(427 Suppl):S129-37. Review.
Metalloproteinases: their role in arthritis and potential as therapeutic targets.
Clark IM, Parker AE.
Expert Opin Ther Targets. 2003 Feb;7(1):19-34. Review.
Matrix metalloproteinases and the regulation of tissue remodelling.
Page-McCaw A, Ewald AJ, Werb Z.
Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33. Review.
Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development.
Little CB, Meeker CT, Hembry RM, Sims NA, Lawlor KE, Golub SB, Last K, Fosang AJ.
Mol Cell Biol. 2005 Apr;25(8):3388-99.
Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E.
Arthritis Rheum. 2005 Oct;52(10):3239-47.
Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases.
Milner JM, Cawston TE.
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):363-75. Review.
Unraveling metalloproteinase function in skeletal biology and disease using genetically altered mice.
Aiken A, Khokha R.
Biochim Biophys Acta. 2010 Jan;1803(1):121-32. Epub 2009 Jul 17. Review.
Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ.
Front Biosci. 2006 May 1;11:1696-701. Review.
Understanding the role of tissue degrading enzymes and their inhibitors in development and disease.
Cawston TE, Wilson AJ.
Best Pract Res Clin Rheumatol. 2006 Oct;20(5):983-1002. Review.
Matrix metalloproteinases: role in skeletal development and growth plate disorders.
Front Biosci. 2006 May 1;11:1702-15. Review.
Matrix metalloproteinases in repair.
Parks WC.
Wound Repair Regen. 1999 Nov-Dec;7(6):423-32. Review.
How proteases regulate bone morphogenesis.
Ortega N, Behonick D, Stickens D, Werb Z.
Ann N Y Acad Sci. 2003 May;995:109-16. Review.
The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.
Elliott S, Cawston T.
Drugs Aging. 2001;18(2):87-99. Review.
Matrix metalloproteinase dependent and independent collagen degradation.
Song F, Wisithphrom K, Zhou J, Windsor LJ.
Front Biosci. 2006 Sep 1;11:3100-20. Review.
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.
[Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F, Uzuki M, Kaneko C, Rikimaru A, Kokubun S, Sawai T.
Ryumachi. 1997 Oct;37(5):688-95. Japanese.
What are the roles of metalloproteinases in cartilage and bone damage?
Murphy G, Lee MH.
Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv44-7. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on